135 related articles for article (PubMed ID: 24606577)
1. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes: a multicentre study.
Sano H; Kobayashi R; Tanaka J; Hashino S; Ota S; Torimoto Y; Kakinoki Y; Yamamoto S; Kurosawa M; Hatakeyama N; Haseyama Y; Sakai H; Sato K; Fukuhara T
Br J Haematol; 2014 Jun; 165(6):786-92. PubMed ID: 24606577
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
3. [Lymphoma-associated hemophagocytic syndrome in Japan].
Takahashi N; Chubachi A; Miura I; Nakamura S; Miura AB
Rinsho Ketsueki; 1999 Jul; 40(7):542-9. PubMed ID: 10483136
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognosis of lymphoma-associated hemophagocytic syndrome].
Zhao AL; Li M; Li LF; Gan XA; Wang J; Li H; Shen K; Yang YF; Niu T
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2173-2180. PubMed ID: 35872581
[No Abstract] [Full Text] [Related]
5. A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis.
Bigenwald C; Fardet L; Coppo P; Meignin V; Lazure T; Fabiani B; Kohn M; Oksenhendler E; Boutboul D; Uzzan M; Lambotte O; Galicier L
Br J Haematol; 2018 Oct; 183(1):68-75. PubMed ID: 30043391
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
7. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma-associated hemophagocytic syndrome: a retrospective study from a single center.
Li N; Jiang M; Wu WC; Zhou HJ; Zou LQ
Hematology; 2022 Dec; 27(1):909-916. PubMed ID: 35993333
[TBL] [Abstract][Full Text] [Related]
9. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
12. [Lymphoma-associated hemophagocytic syndrome(LAHS)].
Takahashi N
Nihon Rinsho; 2000 Mar; 58(3):665-8. PubMed ID: 10741143
[TBL] [Abstract][Full Text] [Related]
13. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
14. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
15. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients.
Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T
Front Immunol; 2022; 13():882589. PubMed ID: 35479073
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
Yao S; Jin Z; He L; Zhang R; Liu M; Hua Z; Wang Z; Wang Y
Front Oncol; 2021; 11():788056. PubMed ID: 34938663
[TBL] [Abstract][Full Text] [Related]
18. IP-10/CXCL10 and MIG/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome.
Maruoka H; Inoue D; Takiuchi Y; Nagano S; Arima H; Tabata S; Matsushita A; Ishikawa T; Oita T; Takahashi T
Ann Hematol; 2014 Mar; 93(3):393-401. PubMed ID: 23975214
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.
Arca M; Fardet L; Galicier L; Rivière S; Marzac C; Aumont C; Lambotte O; Coppo P
Br J Haematol; 2015 Jan; 168(1):63-8. PubMed ID: 25157895
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of lymphocyte function by IFN-γ secretion capability assay in the diagnosis of lymphoma-associated hemophagocytic syndrome.
Hou H; Luo Y; Wang F; Yu J; Li D; Sun Z
Hum Immunol; 2019 Dec; 80(12):1006-1011. PubMed ID: 31540793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
